Long non-coding RNAs in non-small cell lung cancer: Functions and distinctions from other malignancies

15Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Lung cancer leads to the most cancer-related death in the world. It was shown from the increasing evidences that long non-coding RNAs (lncRNAs) are emerging as molecules for diagnosis, prognosis and even therapy of lung cancer and other malignancies. The biological functions or involved signaling pathways of lncRNAs are always found to be inconsistent among different types of malignancies. However, no available literature has systemically summarized differences in the functions and underlying molecular mechanisms of lncRNAs between lung cancer and other cancers. In this review, the biological functions and molecular mechanisms of lncRNAs in lung cancer were introduced. Furthermore, their functional differences between lung cancer and other malignancies were discussed. Finally, their potential clinical applications in future lung cancer therapy were focused on.

Cite

CITATION STYLE

APA

Wang, M., Sun, X., Wang, H., Xin, Y., & Jiao, W. (2019). Long non-coding RNAs in non-small cell lung cancer: Functions and distinctions from other malignancies. Translational Cancer Research. AME Publishing Company. https://doi.org/10.21037/tcr.2019.10.22

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free